Related Experiment Videos
New targets for modifying mast cell activation in asthma.
1Respiratory Research Group, School of Medicine and Dentistry, The Queen's University of Belfast, Institute of Clinical Science, Grosvenor Road, Belfast BT12 6BJ, UK. m.ennis@qub.ac.uk
Current Allergy and Asthma Reports
|April 4, 2006
Summary
This study reviews potential targets for modifying mast cell activation in asthma. It discusses current and speculative agents, including tryptase inhibitors and HMG-CoA reductase inhibitors, examining their effects on human lung mast cells.
Area of Science:
- Immunology
- Pharmacology
- Respiratory Medicine
Background:
- Mast cells are key players in innate immunity and asthma.
- Current asthma treatments include beta-agonists and steroids.
- Newer therapies like leukotriene-receptor antagonists and anti-IgE are emerging.
Purpose of the Study:
- To review potential therapeutic targets for modulating mast cell activation in asthma.
- To assess existing and novel agents affecting mast cells.
Main Methods:
- Literature review of potential mast cell targets in asthma.
- Analysis of agents' actions on human lung mast cells where data is available.
Main Results:
- Identified current targets like tryptase inhibitors undergoing clinical trials.
- Highlighted speculative targets such as HMG-CoA reductase inhibitors.
- Described the effects of various agents on human lung mast cells.
Conclusions:
- Several targets exist for modifying mast cell activation in asthma.
- Therapeutic strategies are evolving beyond traditional treatments.
- Further research into novel agents holds promise for asthma management.